# Treatment of Autism in Children and Adolescents

> **NCT00005014** · PHASE3 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 101 (actual)

## Conditions studied

- Autistic Disorder

## Interventions

- **DRUG:** Risperidone

## Key facts

- **NCT ID:** NCT00005014
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-10
- **Primary completion:** —
- **Final completion:** 2001-02
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2014-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00005014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00005014, "Treatment of Autism in Children and Adolescents". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00005014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*